REGENXBIO, Inc. (RGNX)

9.27 +0.23 (+2.54%) USD  |  NASDAQ  |  Mar 02, 16:00
9.42 +0.15 (+1.62%) After-Hours: 18:37
More

REGENXBIO Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Omeros Corp. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade